Article · 30 Jun 2026
ArticlePublished 10 Apr 2020
Testing for SARS-CoV-2 Portuguese Experience: Clinical, Ethical and Economical Perspectives
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Portugal, unlike its neighbors, Spain and Italy, has so far managed to maintain the flattening of the epidemiological curve of Infections by SARS-CoV 2. The pandemic response strategy in this country included the implementation of measures commonly referred to as non-pharmacological, as well as the rapid growth of responsiveness to perform RTPCR tests for the diagnosis of COVID-19. The clinical and epidemiological reflection of the measures adopted political and economic considerations, is made, and ends with a bioethical analysis of the methodologies implemented.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Research & Bioethics.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Research & Bioethics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Goncalves MA”
- BylineArticles whose byline prints “Menezes L. Goncalves MM”
